Estimaciones de analistas de Wall Street para John B. Sanfilippo & Son, Inc. (JBSS): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-04 | $1.72 | ||
| 2026-08-19 | $0.71 | $1.17 | -39.3% |
| 2026-04-29 | $1.43 | $1.16 | +23.3% |
| 2026-01-29 | $1.53 | $1.36 | +12.5% |
| 2025-10-29 | $1.59 | $1.28 | +24.2% |
| 2025-08-20 | $1.15 | ||
| 2025-04-30 | $1.72 | ||
| 2025-01-29 | $1.16 |
Ratios de valoración
| Ratio P/E | 12.55 |
| Precio / Valor contable | 2.04 |
| EV / EBITDA | 7.89 |
| Rentabilidad por dividendo | 6.78% |
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $846.6M | $888.6M | $876.2M | $880.1M | $858.5M | $955.9M | $999.7M | $1.07B | $1.11B | $1.18B |
| Coste de Ventas | $704.7M | $749.8M | $717.9M | $704.3M | $673.5M | $756.2M | $788.1M | $852.6M | $903.8M | $964.5M |
| Beneficio Bruto | $141.9M | $138.8M | $158.3M | $175.8M | $185.0M | $199.6M | $211.6M | $214.1M | $203.5M | $211.2M |
| I+D | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Generales y Administrativos | $82.7M | $84.1M | $100.8M | $98.8M | $101.2M | $115.9M | $122.7M | $132.5M | $120.6M | $124.2M |
| Gastos Operativos | $84.9M | $84.1M | $100.8M | $97.2M | $99.8M | $112.2M | $121.4M | $129.0M | $118.8M | $124.2M |
| Beneficio Operativo | $58.3M | $56.1M | $54.4M | $78.5M | $85.2M | $87.4M | $90.2M | $85.2M | $84.7M | $87.0M |
| EBITDA | $72.6M | $68.2M | $72.5M | $92.7M | $99.6M | $103.3M | $109.6M | $109.1M | $112.9M | $118.7M |
| Gastos por Intereses | $2.9M | $3.5M | $3.1M | $2.0M | $1.4M | $1.9M | $2.2M | $2.5M | $3.6M | $2.4M |
| Beneficio Antes de Impuestos | $54.1M | $49.3M | $52.4M | $72.7M | $79.8M | $81.7M | $85.3M | $79.9M | $77.9M | $83.0M |
| Impuestos | $18.0M | $16.9M | $13.0M | $18.6M | $20.1M | $19.9M | $22.5M | $19.7M | $18.9M | $21.0M |
| Beneficio Neto | $36.1M | $32.4M | $39.5M | $54.1M | $59.7M | $61.8M | $62.9M | $60.2M | $58.9M | $61.9M |
| BPA | $3.19 | $2.85 | $3.45 | $4.72 | $5.19 | $5.36 | $5.43 | $5.19 | $5.06 | $5.29 |
| BPA Diluido | $3.17 | $2.83 | $3.43 | $4.69 | $5.17 | $5.33 | $5.40 | $5.15 | $5.03 | $5.26 |
| Acciones en Circulación (Diluidas) | $11.4M | $11.4M | $11.5M | $11.5M | $11.6M | $11.6M | $11.6M | $11.7M | $11.7M | $11.8M |
Precio
| Precio | $68.55 |
| Capitalización | $801M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ABVE · BYND · HLF · KLC · NGVC · SENEA · STKL
Explorar sector: Consumer Defensive · Packaged Foods
Más secciones de JBSS: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones